Clinical significance of the tumor markers CYFRA 21-1 and neuron-specific enolase in lung cancer

被引：0
作者：
N. E. Kushlinskii
N. V. Lyubimova
A. O. Lemeshko
A. V. Vasil’ev
M. I. Davydov
机构：
[1] Russian Academy of Medical Sciences,Laboratory of Clinical Biochemistry, Department of Thoracal Oncology, Department of Pathological Anatomy of Human Tumors, Research Institute Clinical Oncology, N. N. Blokhin Oncology Research Center
来源：
Bulletin of Experimental Biology and Medicine | 1997年 / 123卷
关键词：
tumor markers; CYFRA 21-1; neuron-specific enolase; lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The diagnostic validity of CYFRA 21-1 and neuron-specific enolase is assessed in patients with lung cancer. Serum contents of CYFRA 21-1 and neuron-specific enolase are increased, respectively, in 74 and 67% of patients with various histological variants of lung cancer. Diagnostic sensitivity of CYFRA was 77.2% in lung cancer other than the small cell variant and 76% in small cell lung cancer. A correlation between the CYFRA content and the tumor size in patients with squamous and other than small cell lung cancer is demonstrated. In patients with spread small cell cancer, serum enolase content tends to increase compared with that in patients with localized small cell cancer. Both CYFRA and enolase are sensitive lung tumor markers in the diagnostics and evaluation of the extent of tumor spread.
引用
收藏
页码：85 / 87
页数：2
相关论文
共 50 条
[41]   Potentials of neuron-specific enolase as a biomarker for gastric cancer [J].
Wang, Lingyun ;
Hu, Ruirui ;
Liu, Hongmei ;
Li, Wen ;
Zhou, Lili ;
Liu, Xiangyu ;
Ding, Yuanyuan .
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (03) :505-511
[42]   EVALUATION OF NEURON-SPECIFIC ENOLASE, TISSUE POLYPEPTIDE ANTIGEN, AND CARCINOEMBRYONIC ANTIGEN AS MARKERS FOR STAGING AND MONITORING RESPONSE TO THERAPY OF LUNG-CANCER [J].
SPINAZZI, A ;
SORESI, E ;
BOFFI, R ;
NONIS, A ;
NOSEDA, A ;
COBELLI, S ;
SCANNI, A .
CANCER DETECTION AND PREVENTION, 1994, 18 (03) :209-220
[43]   Multifunctional neuron-specific enolase: its role in lung diseases [J].
Xu, Cai-Ming ;
Luo, Ya-Lan ;
Li, Shuai ;
Li, Zhao-Xia ;
Jiang, Liu ;
Zhang, Gui-Xin ;
Owusu, Lawrence ;
Chen, Hai-Long .
BIOSCIENCE REPORTS, 2019, 39
[44]   NEURON-SPECIFIC ENOLASE AS A TUMOR-MARKER IN METASTATIC MELANOMA [J].
BUZAID, AC ;
SANDLER, AB ;
HAYDEN, CL ;
SCINTO, J ;
POO, WJ ;
CLARK, MB ;
HOTCHKISS, S .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (05) :430-431
[45]   Sputum carcinoembryonic antigen, neuron-specific enolase and cytokeratin fragment 19 levels in lung cancer diagnosis [J].
Kalomenidis, A ;
Dimakou, K ;
Kolintza, A ;
Vlami, K ;
Papadakis, M ;
Sotiropoulou, C ;
Orphanidou, D ;
Roussos, C ;
Papiris, S .
RESPIROLOGY, 2004, 9 (01) :54-59
[46]   Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary bladder [J].
Naito, Akihiro ;
Taguchi, Satoru ;
Nakagawa, Tohru ;
Matsumoto, Akihiko ;
Nagase, Yasushi ;
Tabata, Mariko ;
Miyakawa, Jimpei ;
Suzuki, Motofumi ;
Nishimatsu, Hiroaki ;
Enomoto, Yutaka ;
Takahashi, Shintaro ;
Okaneya, Toshikazu ;
Yamada, Daisuke ;
Tachikawa, Takamitsu ;
Minowada, Shigeru ;
Fujimura, Tetsuya ;
Fukuhara, Hiroshi ;
Kume, Haruki ;
Homma, Yukio .
WORLD JOURNAL OF UROLOGY, 2017, 35 (01) :97-103
[47]   NEURON-SPECIFIC ENOLASE AS A MARKER OF INVITRO NEURONAL DAMAGE .1. ASSESSMENT OF NEURON-SPECIFIC ENOLASE AS A QUANTITATIVE AND SPECIFIC MARKER OF NEURONAL DAMAGE [J].
HANS, P ;
BONHOMME, V ;
COLLETTE, J ;
MOONEN, G .
JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 1993, 5 (02) :111-116
[48]   Measurement of Serum Neuron-Specific Enolase in Neuroblastoma: Is There a Clinical Role? [J].
Ferraro, Simona ;
Braga, Federica ;
Luksch, Roberto ;
Terenziani, Monica ;
Caruso, Simone ;
Panteghini, Mauro .
CLINICAL CHEMISTRY, 2020, 66 (05) :667-675
[49]   Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases [J].
Schneider, J ;
Philipp, M ;
Velcovsky, HG ;
Morr, H ;
Katz, N .
ANTICANCER RESEARCH, 2003, 23 (2A) :885-893
[50]   Is CEA Better than CYFRA 21-1 in the Monitoring of Squamous Cell Lung Cancer Progression? [J].
Lo Russo, Giuseppe ;
Franchi, Fabrizio ;
Seminara, Patrizia .
MEDICAL PRINCIPLES AND PRACTICE, 2010, 20 (02) :200-200
12345